26.76

0.45% 0.12

After Hours: 26.76

Veracyte Inc (VCYT)

Overview News Price History Option Chain Financials Discussions Forecast

Veracyte Inc stock is traded at $26.76, with a volume of 745.85K. It is up +0.45% in the last 24 hours and down -8.36% over the past month. Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.

Previous Close:

$26.64

Open:

$26.42

24h Volume:

745.85K

Relative Volume:

0.76

Market Cap:

$2.18B

Revenue:

$399.58M

Net Income/Loss:

$-54.04M

P/E Ratio:

-35.68

EPS:

-0.75

Net Cash Flow:

$40.13M

1W Performance:

-4.02%

1M Performance:

-8.36%

6M Performance:

-36.65%

1Y Performance:

+25.16%

1-Day Range:

$25.91

$26.84

1-Week Range:

$25.85

$28.43

52-Week Range:

$19.73

$47.32

Veracyte Inc Stock (VCYT) Company Profile

Name

Veracyte Inc

Sector

Healthcare (1172)

Industry

Diagnostics & Research (54)

Phone

(650) 243-6300

Address

6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA

Employee

824

Twitter

@veracyte

Next Earnings Date

2025-02-24

Latest SEC Filings

VCYT's Discussions on Twitter

Compare VCYT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VCYT Veracyte Inc	26.76	2.18B	399.58M	-54.04M	40.13M	-0.75
TMO Thermo Fisher Scientific Inc	390.26	156.49B	42.90B	6.52B	6.72B	17.05
DHR Danaher Corp	195.75	145.01B	23.82B	3.77B	4.90B	5.15
IDXX Idexx Laboratories Inc	520.59	42.30B	3.93B	894.97M	837.70M	10.82
A Agilent Technologies Inc	116.09	34.24B	6.63B	1.17B	1.19B	4.05
IQV Iqvia Holdings Inc	154.10	27.64B	15.50B	1.33B	2.16B	7.34

Veracyte Inc Stock (VCYT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-20-25	Initiated	Craig Hallum	Buy
Dec-05-24	Downgrade	Goldman	Buy → Neutral
Nov-15-24	Initiated	Wolfe Research	Outperform
Oct-16-24	Initiated	UBS	Buy
Oct-10-24	Initiated	Guggenheim	Buy
Feb-23-24	Reiterated	Needham	Buy
Jan-18-23	Downgrade	Raymond James	Outperform → Mkt Perform
Jan-05-23	Initiated	Scotiabank	Sector Outperform
Jan-07-22	Initiated	Stephens	Overweight
Nov-18-21	Resumed	Goldman	Buy
Jun-15-21	Initiated	Raymond James	Outperform
Feb-18-21	Resumed	Needham	Buy
Jan-28-21	Initiated	Truist	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-09-20	Initiated	Morgan Stanley	Underweight
Jul-31-19	Initiated	Lake Street	Buy
Jul-02-19	Initiated	Needham	Buy
Nov-29-18	Downgrade	Janney	Buy → Neutral
Oct-31-18	Upgrade	Janney	Neutral → Buy
Nov-07-17	Downgrade	Janney	Buy → Neutral
Nov-07-17	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-31-17	Resumed	BTIG Research	Buy
Nov-14-16	Resumed	Leerink Partners	Outperform
Dec-18-15	Initiated	Cantor Fitzgerald	Buy
Jun-11-15	Reiterated	Leerink Partners	Outperform
Nov-26-13	Initiated	William Blair	Outperform

View All

Veracyte Inc Stock (VCYT) Latest News

Jun 17, 2025

Insider Sell: Karin Eastham Sells Shares of Veracyte Inc (VCYT) - GuruFocus

Jun 17, 2025

Jun 15, 2025

Veracyte, Inc.'s (NASDAQ:VCYT) Shares Lagging The Industry But So Is The Business - simplywall.st

Jun 15, 2025

Jun 09, 2025

Veracyte (VCYT) Fell Despite Reporting Revenue Growth and Improved Profitability - Insider Monkey

Jun 09, 2025

Jun 07, 2025

Cathie Wood's Ark Invest Loads Up On Veracyte, Offloads 3D Systems - Benzinga

Jun 07, 2025

Jun 06, 2025

Insider Selling: John Leite Sells Shares of Veracyte Inc (VCYT) - GuruFocus

Jun 06, 2025

Veracyte chief commercial officer sells shares for $76,409 By Investing.com - Investing.com Canada

Jun 06, 2025

Veracyte chief commercial officer sells shares for $76,409 - Investing.com Australia

Jun 06, 2025

Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock By Investing.com - Investing.com South Africa

Jun 06, 2025

Cathie Wood’s ARK buys Veracyte, sells AvidXchange and 3D Systems stock - Investing.com Nigeria

Jun 06, 2025

Veracyte (VCYT) Down 13.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Jun 06, 2025

Jun 05, 2025

Top Companies in the NASDAQ Veracyte and Others by Kalkine - Kalkine Media

Jun 05, 2025

Two Sigma Advisers LP Cuts Stock Position in Veracyte, Inc. (NASDAQ:VCYT) - Defense World

Jun 05, 2025

Veracyte at Jefferies Global Healthcare Conference: Strategic Growth and Innovation - Investing.com Nigeria

Jun 05, 2025

Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant By Investing.com - Investing.com Nigeria

Jun 04, 2025

Cathie Wood’s ARK sells Palantir and Roblox, buys Veracyte and Guardant - Investing.com Australia

Jun 04, 2025

Veracyte (VCYT) Shares Pulled Back Despite Beating Expectations - MSN

Jun 04, 2025

Veracyte at William Blair Growth Stock Conference: Strategic Insights Unveiled - Investing.com Canada

Jun 04, 2025

Jun 01, 2025

Veracyte (NASDAQ:VCYT) Stock Rating Lowered by Wall Street Zen - Defense World

Jun 01, 2025

May 31, 2025